Zhao Yan New Drug (06127.HK): Zhao Yan (Suzhou) New Drug subscribed to Industrial and Commercial Bank's wealth management product totaling 40 million yuan.

The Smart Financial News APP reported that Zhao Yan Pharmaceuticals (06127.HK) announced that on September 19, 2025 (after trading hours), the group member company Zhao Yan (Suzhou) Pharmaceuticals has just entered into an agreement with Industrial and Commercial Bank to subscribe to two Industrial and Commercial Bank wealth management products totaling RMB 40 million. Together with the announcement date, the total investment amount of these Industrial and Commercial Bank wealth management products that have not yet been redeemed is RMB 410 million.